You are here : Home Healthcare Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market Drug formulations ATC Antiinfectives for Systemic Use

Global Vaccines Market Research Report

Vaccines and its peer markets - E-Clinical Trial Solutions, Wireless Health, Proteomics, Antibacterials for systemic use, Antivirals for systemic use, Healthcare IT outsourcing, Chromatography Instruments, Chromatography, Immunoassay and 6 other markets - adds up to total Antiinfectives for Systemic Use market.

Vaccines can be segmented by Types, Indications, Geographies, Submarkets and Technologies. Types of this market are Preventive and Therapeutic. Indications of this market are Infectious disease, Cancer and Allergies. Geographies of this market are North America, Europe, Asia-Pacific and Rest of World. Submarkets of this market are Bacterial vaccines, Viral vaccines, Bacterial and viral vaccines, combined, Other vaccines and Animal Vaccines. Technologies of this market are Live Attenuated Vaccines (LAV), Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, Dna Vaccines, Synthetic Vaccines and Dentritic Vaccines.

Key Questions Answered

What are market estimates and forecasts; which of Vaccines markets are doing well and which are not?

What makes our report unique?

This reports provides most granular segmentation on Bacterial vaccines, Viral vaccines, Bacterial and viral vaccines, combined and Other vaccines.
This report provides market sizing and forecast for the Vaccines market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.

Audience for this report

Global Vaccines companies
Manufacturing Companies
Traders, distributors, and suppliers
Governmental and research organizations
Associations and industry bodies
Technology providers

Top developments

Growing Prevalence Of Animal Diseases Will Result In Employing Preventive Measures Like Vaccines
Increasing Incidences Of Zoonotic Diseases In Humans Will Propel The Vaccines Market
Increasing Investments By Various Government Agencies, Animal Associations, & Leading Players To Propel
Continuous Innovations & Introduction Of New Products Propels The Market
Rising Maintenance Costs For Storage Of Vaccines, A Burden On Manufacturers & Distributors
Increasing Adoption Of Vegetarian Food In Major Economies Owing To Increasing Risk Of Obesity And Other Chronic Disorders
Persistent Economic Slowdown To Affect Growth

	PRODUCT TITLE	PUBLISHED
	Bacterial vaccines Bacterial vaccines and Viral vaccines, Bacterial...	Upcoming
	Viral vaccines Viral vaccines and Bacterial vaccines,	Upcoming
	Bacterial and viral vaccines, combined Bacterial and viral vaccines, combined and Bacterial vaccines, Viral...	Upcoming
	Global Live Attenuated Vaccines (LAV) Market The Global Live Attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $2515 million in 2013 and expected to be $3633 million by 2018 at a CAGR of 7.6%. Live Attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.	Upcoming
	Global Inactivated Vaccines Market The Global Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $1958 million in 2013 and expected to be $2974million by 2018 at a CAGR of 8.7%. Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.	Upcoming
	Global Sub-unit Vaccines Market The Global Subunit Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $91 million in 2013 and expected to be $134 million by 2018 at a CAGR of 8.1%. Subunit Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.	Upcoming
	Global Toxoid Vaccines Market The Global Toxoid Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $468.1 million in 2013 and expected to be $644.8 million by 2018 at a CAGR of 6.6%. Toxoid Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.	Upcoming
	Global Conjugate Vaccines Market The global conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $201.1 million in 2013 and is expected to reach $305.2 million by 2018 at a CAGR of 8.7% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.	Upcoming
	Global Recombinant Vaccines Market The Global Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $368.9 million in 2013 and expected to be $550.8 million by 2018 at a CAGR of 8.3%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.	Upcoming
	Global Dna Vaccines Market The global DNA animal vaccine market is mainly driven by growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $142.5 million in 2013 and is expected to reach $232.4 million by 2018, at a CAGR of 10.3% for the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.	Upcoming
	Animal Vaccines Animal Vaccines and Bacterial vaccines, Viral vaccines,	Upcoming
	Synthetic Vaccines Synthetic Vaccines and Live Attenuated Vaccines (LAV),	Upcoming
	Dentritic Vaccines Dentritic Vaccines and Live Attenuated Vaccines (LAV),	Upcoming
	Canine Vaccines Canine Vaccines and Feline Vaccines adds up to total Companion animal vaccines market. Canine Vaccines can be segmented by Types, Geographies,...	Upcoming
	Feline Vaccines Feline Vaccines and Canine Vaccines adds up to total Companion animal vaccines market. Feline Vaccines can be segmented by Types, Geographies,...	Upcoming
	Bovine Vaccines Bovine Vaccines and Small Ruminant Vaccines adds up to total Livestock market. Bovine Vaccines can be segmented by Types, Geographies,...	Upcoming
	Small Ruminant Vaccines Small Ruminant Vaccines and Bovine Vaccines adds up to total Livestock market. Small Ruminant Vaccines can be segmented by Types, Geographies,...	Upcoming
	Infectious Bronchitis Infectious Bronchitis and Gumboro Disease, Avian Influenza,	Upcoming
	Gumboro Disease Gumboro Disease and Infectious Bronchitis, Avian Influenza,...	Upcoming
	Avian Influenza Avian Influenza and Infectious Bronchitis, Gumboro Disease,...	Upcoming

<
1 | 2 | 3
>
>>

55 reports | Show

Connect With Us

US/CAN : +1-888-502-0539

sales@micromarketmonitor.com

Subscription

Vaccines